Skip to main content

Massive Leap in Medical AI: Why General Models Outperform Specialized Clinical Tools

Ilustrační obrázek
A study published in the prestigious scientific journal Nature represents a fundamental breakthrough in understanding the capabilities of artificial intelligence. Until now, it was believed that for critical areas such as medicine, specialized models trained on narrow datasets would always prevail. The reality, however, is different: general-purpose language models (General-purpose LLMs), such as the GPT, Gemini, or Claude families, are now outperforming specialized clinical AI tools in key medical tests.

For many years, a debate has been ongoing in the AI developer community: does it make sense to train huge models on everything possible, or is it better to create a "digital doctor" who only knows medical literature? The results of the latest research suggest that the path to absolute accuracy in medicine leads through the extreme reasoning ability offered by the largest general models.

End of narrow model dominance?

The traditional approach to medical AI involved taking existing models and performing their fine-tuning on specific medical data. The goal was to create a tool that would understand terminology and diagnoses better than any general model. However, according to the findings of scientists in Nature, this approach is reaching its limits.

General models, such as GPT-5 or Gemini 3, possess an enormous degree of "common sense" and the ability to synthesize information from various fields. Medicine is not just about memorizing terms; it's about understanding context, relationships between symptoms, and logically drawing conclusions. It is precisely in this area, namely in logical reasoning, that general models crush specialized systems, which are often too rigid and lack broader context.

Benchmarks: Where the rubber meets the road

When tested on standard medical benchmarks (test sets of questions and answers), general models showed higher scores in complex tasks requiring the interpretation of case studies. While a specialized model can perfectly identify a rare disease from keywords, a general model can better understand the nuances in a patient's description, leading to more accurate prediction.

It is important to realize, however, that this does not mean that specialized models are worthless. As expert David Talby from John Snow Labs states, medicine is an extremely complex and regulated field. The problem with general models remains hallucination (making up facts) and specific terminological ambiguities. For example, the abbreviation "RA" can mean rheumatoid arthritis, but in another context, it can refer to the right atrium of the heart. Here, the model's ability to correctly interpret the contextual space still plays a role.

Comparison of leading models in a medical context

If we were to compare the current market leaders, the situation looks as follows:

  • GPT (OpenAI): Currently the best in logical reasoning and synthesis of complex medical texts. Excellent for analyzing patient histories.
  • Gemini (Google): Excels due to integration with extensive data sources and the ability to work with multimodal inputs (e.g., interpreting X-ray images in combination with text).
  • Claude (Anthropic): Often preferred for its higher degree of "safety tuning," which is crucial in medicine for minimizing risky responses.

For a Czech user or a medical healthcare facility, it is important to know that these models are available via API or subscription. For example, ChatGPT Plus costs approximately 20 USD (approx. 460 CZK) per month, while enterprise solutions for hospitals are governed by different pricing models based on data volume.

Practical impact: What does this mean for Czechia and the EU?

This research has fundamental implications for the implementation of AI in Czech healthcare. Before we start relying on AI for diagnosis, we must protect two things: data privacy and regulation.

Within the European Union, the strict EU AI Act applies. Medical systems are classified as high-risk. This means that even if a general model like GPT-5 shows excellent results in tests, its deployment in the Czech hospital system must meet extreme demands for transparency, explainability, and data security. We cannot simply "connect ChatGPT to a patient database".

For Czech doctors and developers, this means that the future path will not be in attempting to create "our own model from scratch," but in building a layer on top of general models. This layer will be responsible for ensuring that patient data never leaves the EU (solutions using local instances or Azure OpenAI within EU regions) and that the model's output is always validated by a doctor.

Availability and language

The good news is that modern models like Gemini or GPT are showing increasingly better capabilities in Czech localization. Even though they are not primarily trained on Czech medical texts, their ability to translate and understand context allows for quality work even with Czech terminology, which is crucial for our doctors.

Conclusion

The result of the Nature study changes the rules of the game. The future of medical AI will not lie in isolated, narrow systems, but in intelligent applications built on new models with enormous reasoning capacity. The key to success will be the ability to safely "flavor" these models using specialized data and strict regulatory frameworks.

Can I use general ChatGPT for my own diagnosis?

Never. Even though models achieve excellent results in benchmarks, they can still hallucinate and lack clinical responsibility. AI in medicine serves as a doctor's assistant, not as a substitute for diagnosis.

What are the risks of using general models in hospitals?

The main risks are personal data protection (GDPR) and the possibility that the model generates incorrect information that looks very convincing. Therefore, it is necessary to use models in closed, secure clouds complying with EU standards.

Will specialized medical tools continue to evolve?

Yes, but their role will change. Instead of trying to "know everything," they will focus on how best to leverage the capabilities of large models and connect them with real clinical processes and certified data.

X

Don't miss out!

Subscribe for the latest news and updates.